Table 1 Patient characteristics with the median, lower and upper quartiles of their GLTEQ, FACT-G and FACIT-F scores

Gender

 Male

38 (58)

15 (3.8–31)

0.92

70.7 (58.1–94.1)

0.56

31 (16.8–40.3)

0.99

 Female

26 (40)

12 (0–36)

76.4 (63.8–95.3)

34 (17.5–44.7)

 Not specified

1 (2)

Age group

 Less than 45

1 (2)

Missing

0.07

48

0.049

16

0.28

 45–54

7 (11)

7.5 (0–43.5)

63.3 (37.4–86)

26 (13–31)

 55–64

18 (28)

12 (7.5–23)

69.8 (59.1–92.8)

35.5 (20.5–43.8)

 65–75

27 (42)

21 (6–39)

84.4 (69.5–100.7)

35 (24–48)

 Over 75

12 (18)

1.5 (0–15.8)

65.4 (46.8–90.9)

23 (10–44.4)

Years since MM diagnosis

 Less than 1

9 (14)

19.5 (1.5–33.3)

0.92

75 (58.1–89.4)

0.75

37 (16–44.7)

0.57

 1 to 5

28 (43)

15 (6–34.5)

71.5 (55.7–94)

31 (14.25–39.8)

 6 to 10

14 (22)

15 (3–36)

74.9 (65.8–103.2)

35 (24–49.3)

 Over 10

8 (12)

12 (0–58.6)

80.1 (66.1–95)

34 (23–43)

 Not specified

6 (9)

On myeloma treatment

 Yes

43 (66)

12 (3–21)

0.16

72 (59.1–92.4)

0.37

26.5 (16.8–40.3)

0.34

 No

21 (32)

26.5 (6.8–51)

77.7 (63.5–98)

35 (19.5–48.5)

 Not specified

1 (2)

Line of myeloma treatment

 None

7 (11)

25.5 (0–42.3)

0.43

78.4 (65.3–104)

0.72

39 (23–50)

0.30

 Radiotherapy alone

3 (5)

33

66

17

 1st

17 (26)

20 (7.5–29)

68 (57.2–91.6)

34 (24–39.5)

 2nd

9 (14)

12 (3–28)

76.5 (46.6–97.8)

31 (11.5–50)

 3rd or beyond

17 (26)

9 (0–15)

72.4 (54.4–91.4)

23.5 (14.5–37.8)

 Not specified

12 (18)